The effect of weight loss following 18 months of lifestyle intervention on brain age assessed with resting-state functional connectivity

  1. Gidon Levakov  Is a corresponding author
  2. Alon Kaplan
  3. Anat Yaskolka Meir
  4. Ehud Rinott
  5. Gal Tsaban
  6. Hila Zelicha
  7. Matthias Blüher
  8. Uta Ceglarek
  9. Michael Stumvoll
  10. Ilan Shelef
  11. Galia Avidan
  12. Iris Shai
  1. Ben-Gurion University of the Negev, Israel
  2. University of Leipzig, Germany
  3. Soroka Medical Center, Israel

Abstract

Background: Obesity negatively impacts multiple bodily systems, including the central nervous system. Retrospective studies that estimated chronological age from neuroimaging have found accelerated brain aging in obesity, but it is unclear how this estimation would be affected by weight loss following a lifestyle intervention.

Methods: In a sub-study of 102 participants of the DIRECT-PLUS (dietary-intervention-randomized-controlled-trial polyphenol-unprocessed) trial, we tested the effect of weight loss following 18 months of lifestyle intervention on predicted brain age based on MRI-assessed resting-state functional connectivity (RSFC). We further examined how dynamics in multiple health factors, including anthropometric measurements, blood biomarkers, and fat deposition, can account for changes in brain age.

Results: To establish our method, we first demonstrated that our model could successfully predict chronological age from RSFC in three cohorts (n=291;358;102). We then found that among the DIRECT-PLUS participants, 1% of body weight loss resulted in an 8.9 months attenuation of brain age. Attenuation of brain age was significantly associated with improved liver biomarkers, decreased liver fat, and visceral and deep subcutaneous adipose tissues after 18m of intervention. Finally, we showed that lower consumption of processed food, sweets, and beverages were associated with attenuated brain age.

Conclusions: Successful weight loss following lifestyle intervention might have a beneficial effect on the trajectory of brain aging.

Funding: The German Research Foundation (DFG), German Research Foundation - project number 209933838 - SFB 1052; B11), Israel Ministry of Health grant 87472511 (to I Shai); Israel Ministry of Science and Technology grant 3-13604 (to I Shai); and the California Walnuts Commission (to I Shai).

Clinical Trial: This trial was registered at clinicaltrials.gov as NCT03020186.

Data availability

The code for the brain age prediction model and the calculation of brain age attenuation is openly available online at https://github.com/GidLev/functional_brain_aging. The unprocessed data used for the model training and validation is openly available online at http://fcon_1000.projects.nitrc.org/indi/enhanced/neurodata.html for the eNKI dataset and available upon online access request https://camcan-archive.mrc-cbu.cam.ac.uk/dataaccess/ for the CamCAN dataset. Data from the DIRECT-PLUS trial is not publicly available since it contains information that could compromise the privacy of research participants. However, de-identified data could be shared upon request, subject to approval from the Soroka Medical Center Medical Ethics Board. A processed version of the data that includes participants' demographics, predicted and observed age and weight values for T0 and T18 is available as supplementary information.

The following previously published data sets were used
    1. Nooner
    2. KB
    3. Colcombe
    4. SJ
    5. Tobe
    6. RH
    7. Mennes
    8. M
    9. Benedict
    10. MM
    11. Moreno
    12. AL
    13. Panek
    14. LJ
    15. Brown
    16. S
    17. Zavitz
    18. ST
    19. Li
    20. Q and Sikka
    21. S
    (2012) The NKI-Rockland sample
    Wide array of physiological and psychological assessments, genetic information, and advanced neuroimaging.

Article and author information

Author details

  1. Gidon Levakov

    Department of Cognitive and Brain Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    For correspondence
    gidonle@post.bgu.ac.il
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5520-3556
  2. Alon Kaplan

    Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
  3. Anat Yaskolka Meir

    Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
  4. Ehud Rinott

    Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
  5. Gal Tsaban

    Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
  6. Hila Zelicha

    Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
  7. Matthias Blüher

    Department of Medicine, University of Leipzig, Leipzig, Germany
    Competing interests
    Matthias Blüher, has received consulting fees from Amgen, Astra Zeneca, Boehringer-Ingelheim, Bayer, Lilly, Novo Nordisk, Novartis, Sanofi and Pfizer; and fees for lectures/ presentations from Amgen, Astra Zeneca, Boehringer-Ingelheim, Bayer, Daiichi-Sankyo, Lilly, Novo Nordisk, Novartis, Sanofi and Pfizer. The author is also on the advisory board for Boehringer-Ingelheim. The author has no other competing interests to declare..
  8. Uta Ceglarek

    Department of Medicine, University of Leipzig, Leipzig, Germany
    Competing interests
    No competing interests declared.
  9. Michael Stumvoll

    Department of Medicine, University of Leipzig, Leipzig, Germany
    Competing interests
    No competing interests declared.
  10. Ilan Shelef

    Department of Diagnostic Imaging, Soroka Medical Center, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
  11. Galia Avidan

    Department of Psychology, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2293-3859
  12. Iris Shai

    Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel
    Competing interests
    No competing interests declared.

Funding

The German Research Foundation (209933838 SFB 1052; B11)

  • Iris Shai

Israel Ministry of Health (grant 87472511)

  • Iris Shai

Israel Ministry of Science and Technology (3-13604)

  • Iris Shai

California Walnuts Commission

  • Iris Shai

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: This work was based on a sub-study of the DIREC-PLUS trial (clinicaltrials.gov ID: NCT03020186). The Soroka Medical Center Medical Ethics Board and Institutional Review Board provided ethics approval. All participants provided written consent and received no financial compensation.

Copyright

© 2023, Levakov et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,386
    views
  • 734
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gidon Levakov
  2. Alon Kaplan
  3. Anat Yaskolka Meir
  4. Ehud Rinott
  5. Gal Tsaban
  6. Hila Zelicha
  7. Matthias Blüher
  8. Uta Ceglarek
  9. Michael Stumvoll
  10. Ilan Shelef
  11. Galia Avidan
  12. Iris Shai
(2023)
The effect of weight loss following 18 months of lifestyle intervention on brain age assessed with resting-state functional connectivity
eLife 12:e83604.
https://doi.org/10.7554/eLife.83604

Share this article

https://doi.org/10.7554/eLife.83604

Further reading

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.

    1. Epidemiology and Global Health
    2. Microbiology and Infectious Disease
    Amanda C Perofsky, John Huddleston ... Cécile Viboud
    Research Article

    Influenza viruses continually evolve new antigenic variants, through mutations in epitopes of their major surface proteins, hemagglutinin (HA) and neuraminidase (NA). Antigenic drift potentiates the reinfection of previously infected individuals, but the contribution of this process to variability in annual epidemics is not well understood. Here, we link influenza A(H3N2) virus evolution to regional epidemic dynamics in the United States during 1997—2019. We integrate phenotypic measures of HA antigenic drift and sequence-based measures of HA and NA fitness to infer antigenic and genetic distances between viruses circulating in successive seasons. We estimate the magnitude, severity, timing, transmission rate, age-specific patterns, and subtype dominance of each regional outbreak and find that genetic distance based on broad sets of epitope sites is the strongest evolutionary predictor of A(H3N2) virus epidemiology. Increased HA and NA epitope distance between seasons correlates with larger, more intense epidemics, higher transmission, greater A(H3N2) subtype dominance, and a greater proportion of cases in adults relative to children, consistent with increased population susceptibility. Based on random forest models, A(H1N1) incidence impacts A(H3N2) epidemics to a greater extent than viral evolution, suggesting that subtype interference is a major driver of influenza A virus infection ynamics, presumably via heterosubtypic cross-immunity.